Inactivation of TβRII leads to increased tumor spreading and metastasis in a variety of carcinomas, including colon[113], breast[114], pancreatic[115], intestinal[116] or head and neck squamous cell carcinoma (HNSCC)[117]. The gene discussed is TGFBR2; the disease is carcinoma.